📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Application of a High-Content Screening Assay Utilizing Primary Human Lung Fibroblasts to Identify Antifibrotic Drugs for Rapid Repurposing in COVID-19 Patients. (2021)

First Author: Marwick JA

Attributed to: MICA: A new paradigm for testing pathway tractability in lung disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1177/24725552211019405

PubMed Identifier: 34078171

Publication URI: http://europepmc.org/abstract/MED/34078171

Type: Journal Article/Review

Volume: 26

Parent Publication: SLAS discovery : advancing life sciences R & D

Issue: 9

ISSN: 2472-5552